Jay Venkatesan - 24 Jun 2021 Form 4 Insider Report for Angion Biomedica Corp. (ELTX)

Role: President and Chief Executive Officer and Director, Director
Signature: /s/ Jennifer J. Rhodes, as attorney-in fact for Jay. R. Venkatesan
Issuer symbol: ELTX
Transactions as of: 24 Jun 2021
Net transactions value: -$379,278
Form type: 4
Filing time: 17 Dec 2021, 16:13:23 UTC
Previous filing: 27 May 2022
Next filing: 21 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELTX	Common Stock	Tax liability	$566,234	-41,091	-3.2%	$13.78	1,239,257	24 Jun 2021	Direct	F1
transaction	ELTX	Common Stock	Purchase	$186,956	+77,604	+6.3%	$2.41^*	1,316,861	15 Dec 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were withheld to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs").

Remarks:

President and Chief Executive Officer and Director